Medtronic PLC
(NYSE : MDT)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
MDTMedtronic PLC
1.90%92.090.6%$492.97m
ABTAbbott Laboratories
-2.08%69.070.8%$465.05m
TMOThermo Fisher Scientific Inc.
0.08%233.071.0%$442.01m
ISRGIntuitive Surgical, Inc.
0.18%483.562.4%$441.82m
ALGNAlign Technology, Inc.
2.28%209.086.3%$425.35m
BAXBaxter International Inc.
-1.66%63.941.7%$327.52m
BDXBecton, Dickinson and Company
-1.64%239.411.1%$318.04m
BSXBoston Scientific Corporation
-3.09%34.201.1%$264.70m
EWEdwards Lifesciences Corporation
-0.32%149.401.2%$263.90m
ABMDABIOMED, Inc.
-0.29%298.963.3%$246.04m
SYKStryker Corporation
-1.14%165.811.3%$238.70m
DXCMDexCom, Inc.
-0.84%120.298.5%$181.02m
ZBHZimmer Biomet Holdings, Inc.
-1.17%112.171.7%$143.65m
WATWaters Corporation
-1.02%195.753.5%$138.33m
XRAYDENTSPLY International Inc.
-0.22%36.843.1%$129.38m

Company Profile

Medtronic Plc is a medical technology company, which develop, manufacture, distribute, and sell device-based medical therapies and services. It also provides services to the hospitals, physicians, clinicians, and patients. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The Cardiac and Vascular Group segment consist of three divisions: Cardiac Rhythm & Heart Failure, Coronary & Structural Heart, and Aortic & Peripheral Vascular. The Minimally Invasive Technologies Group segment comprises of three divisions: Surgical Innovations and Respiratory, Gastrointestinal, and Renal. The Restorative Therapies Group contains four divisions: Spine, Brain, Specialty Therapies, and Pain Therapies. The Diabetes Group segment focuses in the development, manufacturing, and marketing of products and services for the management of Type I and Type II diabetes. The company was founded in 1949 and is headquartered in Dublin, Ireland.